The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C

This publication has 6 references indexed in Scilit:

• A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Biochemical Surrogate Markers of Liver Fibrosis and Activity in A Randomized Trial of Peginterferon Alfa–2B and Ribavirin
  Hepatology, 2003
• Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients
  AIDS, 2003
• A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
  Comparative Hepatology, 2002
• Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
  The Lancet, 2001
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.
  Radiology, 1983